Dorthe Ronnau - Coloplast VP Culture
| CLPBY Stock | USD 12.58 0.07 0.56% |
Insider
Dorthe Ronnau is VP Culture of Coloplast A
| Age | 57 |
| Phone | 45 49 11 11 11 |
| Web | https://www.coloplast.com |
Coloplast Management Efficiency
The company has return on total asset (ROA) of 0.1714 % which means that it generated a profit of $0.1714 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7507 %, meaning that it generated $0.7507 on every $100 dollars invested by stockholders. Coloplast's management efficiency ratios could be used to measure how well Coloplast manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Guan Ong | Top Glove | N/A | |
| Donald Major | Precision Optics, | 63 | |
| Aurelio Sahagun | Straumann Holding AG | 50 | |
| Steven MD | Carl Zeiss Meditec | N/A | |
| Andrew Chang | Carl Zeiss Meditec | N/A | |
| Marco Catalani | EssilorLuxottica Socit anonyme | N/A | |
| Mike Wang | Carl Zeiss Meditec | N/A | |
| Euan Thomson | Carl Zeiss Meditec | 60 | |
| Martin Wiechmann | Carl Zeiss Meditec | N/A | |
| MAICSA FCIS | Top Glove | 65 | |
| Ariel Bauer | EssilorLuxottica Socit anonyme | N/A | |
| Daniel Habhegger | Precision Optics, | 54 | |
| Joseph Forkey | Precision Optics, | 56 | |
| Hooi Cheoh | Top Glove | 50 | |
| Giorgio Iannella | EssilorLuxottica Socit anonyme | N/A | |
| KokKien Loh | Straumann Holding AG | 56 | |
| Markus Weber | Carl Zeiss Meditec | N/A | |
| WeiAnn Voon | Top Glove | N/A | |
| Camila Finzi | Straumann Holding AG | 51 | |
| Kean Loke | Top Glove | N/A | |
| Markus Weber | Carl Zeiss Meditec | N/A | |
Management Performance
| Return On Equity | 0.75 | |||
| Return On Asset | 0.17 |
Coloplast A Leadership Team
Elected by the shareholders, the Coloplast's board of directors comprises two types of representatives: Coloplast inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Coloplast. The board's role is to monitor Coloplast's management team and ensure that shareholders' interests are well served. Coloplast's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Coloplast's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ellen Bjurgert, VP Relations | ||
| Allan Rasmussen, Executive VP of Global Operations | ||
| Alain Morvan, Senior Vice President Sales Europe | ||
| Thomas Barfod, Director, Employee Representative | ||
| Nicolai Andersen, Senior Vice President Wound Care | ||
| Anders LonningSkovgaard, CFO, Executive Vice President Member of the Executive Management | ||
| Kristian Villumsen, Executive VP of Chronic Care | ||
| Paul Marcun, Senior Vice President Emerging Markets | ||
| Dorthe Ronnau, VP Culture | ||
| Dennis Kaysen, Director Communications |
Coloplast Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Coloplast a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.75 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 28.84 B | |||
| Shares Outstanding | 2.12 B | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | 37.95 X | |||
| Price To Book | 22.46 X | |||
| Price To Sales | 1.13 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Coloplast Pink Sheet Analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.